Abstract:Background & AimsCellular senescence is frequently present in injured livers. The induction mechanism and the pathological role are not always clear. We aimed to understand the dynamics of senescence induction and progression, and the mechanism responsible for the pathology using a mouse model that disables the essential process of autophagy.MethodsMice deficient in key autophagy genes, Atg7 or Atg5, in the livers were used. Senescence was measured using established cellular and molecular signatures. The mechanistic roles of NRF2, FOXK1 and CCR2 were assessed using mouse genetic models. Liver functions, pathology and tumor development were measured using biochemical and histological approaches.ResultsInducible deletion of Atg7 rapidly upregulated cyclin dependent kinase inhibitors (CDKi) independently of injury and induced senescence-associated β-galactosidase activities and senescence associated secretory phenotype (SASP). Sustained activation of NRF2 was the major factor causing senescence by mediating oxidative DNA damage and upregulating CCL2, a key component of autophagy-related SASP, via the NRF2-FOXK1 axis. Senescence was responsible for hepatic inflammation through CCR2-mediated recruitment of CD11b+ monocytes and CD3+ T cells. CCR2-mediated process in turn enhanced senescence and SASP by upregulating CDKi and chemokines. Thus, senescence and inflammation can mutually augment each other, forming an amplification loop for both events. CCR2-mediated process also modulated liver injury and tumor progression at the later stage of autophagy deficiency related pathology.ConclusionsThese results provide the insight that hepatic senescence can occur early in the disease process, triggers inflammation and is enhanced by inflammation, and has long-term effects on liver injury and tumor progression.

Re: Kanai A, et al. mechanisms of action of botulinum neurotoxins, β3‐adrenergic receptor agonists, and PDE5 inhibitors in modulating detrusor function in overactive bladders: ICI‐RS 2011. Neurourol urodyn 2012;31:300–308

A mitochondria-regulated p53-CCF circuit integrates genome integrity with inflammation

Mitochondrial fatty acid oxidation drives senescence

Total metadrenaline excretion in patients treated with alpha-methyldopa.

Mitochondria are required for pro‐ageing features of the senescent phenotype

Linked regulation of genome integrity and senescence-associated inflammation by p53

Cytoplasmic chromatin triggers inflammation in senescence and cancer

Apoptotic stress causes mtDNA release during senescence and drives the SASP

Spontaneous DNA damage to the nuclear genome promotes senescence, redox imbalance and aging

[Continuous evaluation of subjective problems in knee joints during balneotherapy of gonarthoses].

Ultrastructural studies of the mycelium-to yeast transformation of Sporothrix schenckii

Mitochondrial Quality Control Processes at the Crossroads of Cell Death and Survival: Mechanisms and Signaling Pathways

The Senescence-Associated-Secretory Phenotype constituting HIF-1α activation is independent of micronuclei induction and associated cGAS-mediated interferon response

Chromosomal instability and pro-inflammatory response in aging

Lysosome-mediated Processing of Chromatin in Senescence

Mitochondrial peptides modulate mitochondrial function during cellular senescence

Senescent glia link mitochondrial dysfunction and lipid accumulation

Release of mitochondrial dsRNA into the cytosol is a key driver of the inflammatory phenotype of senescent cells

Crosstalk between the DNA damage response and cellular senescence drives aging and age-related diseases

Cellular senescence: all roads lead to mitochondria

Senescence Connects Autophagy Deficiency to Inflammation and Tumor Progression in the Liver